In the future, we plan to use COE to intervene HCC in animal models and organoids with corresponding EphA2 expression status, in order to obtain more preclinical research data of COE in anti-growth and anti-metastasis. This evidence concerns the gene EPHA2 and hepatocellular carcinoma.